Correlation between serum cystatin C and lipid level in patients with chronic heart failure.
10.11817/j.issn.1672-7347.2023.220025
- Author:
Fengyang NI
1
;
Yu XIANG
2
Author Information
1. Department of Cardiovascular Medicine, 521 Hospital of Norinco Group, Xi'an 710065. single520zx202201@126.com.
2. Department of Cardiovascular Medicine, Shaanxi Provincial People's Hospital, Xi'an 710068, China. single520@126.com.
- Publication Type:Journal Article
- Keywords:
apolipoprotein A;
blood lipid;
chronic heart failure;
cystatin C;
high density lipoprotein
- MeSH:
Humans;
Stroke Volume;
Cystatin C;
Ventricular Function, Left;
Heart Failure;
Lipids;
Chronic Disease
- From:
Journal of Central South University(Medical Sciences)
2023;48(1):34-39
- CountryChina
- Language:English
-
Abstract:
OBJECTIVES:Serum cystatin C (Cys C) and blood lipid levels are related to the occurrence and development of chronic heart failure (CHF). However, there are few reports on the correlation between blood lipid level and serum Cys C level in patients with CHF. The aim of this study is to explore the correlation between serum Cys C level and blood lipid level in patients with CHF, and to provide valuable reference for clinical diagnosis and treatment of CHF.
METHODS:A total of 336 CHF patients who were hospitalized in the Department of Cardiovascular Medicine of Shaanxi Provincial People's Hospital from October 2017 to July 2018 were included and they were divided into a Cys C normal group (n=180) and a Cys C abnormal group (n=156) according to serum Cys C level of the patients. The general data, laboratory indicators, and cardiac ultrasound results were compared between the 2 groups. Pearson correlation analysis was used to detect the correlation between serum Cys C level and blood lipid level and other factors, and the data related to Cys C were further analyzed by multivariate logistic regression.
RESULTS:Compared with the Cys C normal group, patients in the Cys C abnormal group had lower left ventricular ejection fraction (LVEF) (P<0.001), older age (P=0.030), higher incidence rate of diabetes and smoking index (P=0.002 and P=0.003, respectively). The levels of serum creatinine (SCr), blood urea nitrogen (BUN), and total bilirubin (TBIL) were higher (all P<0.001), while the levels of high density lipoprotein (HDL), apolipoprotein (Apo) A, and albumin (ALB) were lower (P<0.001, P=0.001, and P=0.003, respectively) in the Cys C abnormal group. Pearson correlation analysis showed that serum Cys C level was negatively correlated with platelet count, HDL, Apo A, ALB, and LVEF. It was positively correlated with smoking index, mean platelet volume, neutrophil ratio, BUN, and TBIL (all P<0.05). The results of multivariate logistic regression analysis showed that the decreased HDL level was a risk factor for the abnormality of serum Cys C in patients with CHF (OR=0.119, P=0.003), while Apo A was not a risk factor for its abnormality (P=0.337).
CONCLUSIONS:HDL might be the only blood lipid index associated with abnormal serum Cys C in patients with CHF.
